Rheumatoid Vasculitis
Links shared publicly online about this topic
Studies show dramatic decline in rheumatoid vasculitis in US veterans
eurekalert.org — “Researchers at the University of Wisconsin School of Medicine and Public Health examined records of rheumatoid arthritis patients from the national Veterans Health Administration system to determine the prevalence of rheumatoid vasculitis in this population.” View full resource at eurekalert.org
Most Recently Shared on August 27, 2009 at 8:00 am By:
AAAS Studies show dramatic decline in rheumatoid vasculitis in US veterans http://bit.ly/mqS0l
Studies Show Dramatic Decline In Rheumatoid Vasculitis In US Veterans
sciencedaily.com — “Researchers examined records of rheumatoid arthritis (RA) patients from the national Veterans Health Administration (VHA) system to determine the prevalence of rheumatoid vasculitis (RV) in this population. The study found a downward trend in the number of RA patients who go on to develop RV, with a significant drop of 53% among inpatients and 31% among outpatients between 2000 and 2001.” View full resource at sciencedaily.com
Most Recently Shared on November 30, 2009 at 5:24 am By:
Dr Steven Siwek Doctor, Pain Medicine Physician, and Physician
Studies Show Dramatic Decline In Rheumatoid Vasculitis In US Veterans http://bit.ly/6UtgKE
Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis - Hiura - 2011 - Hepatology Research - Wiley Online Library
onlinelibrary.wiley.com — “Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis - Hiura - 2011 - Hepatology Research - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 25, 2011 at 12:34 am By:
Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis: A 71â€*yearâ€*... http://bit.ly/gAgdn2
Avoiding Infertility And Cancer With New Therapy For Vasculitis
medicalnewstoday.com — “Researchers have identified that rituxan, a drug previously approved for the treatment of non-hodgkin's b cell lymphoma and rheumatoid arthritis, can treat severe anca-associated vasculitis as eff” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2009 at 11:39 am By:
Avoiding Infertility And Cancer With New Therapy For Vasculitis: Researchers have identified that Rituxan, a dru.. http://bit.ly/3zU0EY
New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com
latimes.com — “Forty years after the development of the only therapy for vasculitis, a rare but severe disease of blood vessels, researchers have found a new therapy that is at least as effective, requires fewer treatments and promises far fewer side effects. Federally-funded researchers reported Wednesday that treatment with the biotech drug rituximab, already marketed as Rituxan for the treatment of B cell lymphoma and rheumatoid arthritis, is slightly more effective than the existing drug, cyclophosphamide,” View full resource at latimes.com
Most Recently Shared on July 15, 2010 at 8:20 pm By:
Monica R.Gaidhane Doctor and Physician
New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com http://bit.ly/aHnDxU
New therapy for vasculitis will help patients avoid infertility and cancer
physorg.com — “Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy. The news will be presented October 18 at the ...” View full resource at physorg.com
Most Recently Shared on October 18, 2009 at 3:05 pm By:
New therapy for vasculitis will help patients avoid infertility and cancer http://bit.ly/3jGMoP
Rare Blood Vessel Disease Could Have New Treatment Option - Drugs.com MedNews
drugs.com — “A drug already used to treat lymphoma and rheumatoid arthritis shows promise as an option to treat rare forms of vasculitis, a disease affecting the blood vesse” View full resource at drugs.com
Most Recently Shared on July 14, 2010 at 10:18 pm By:
Rare Blood Vessel Disease Could Have New Treatment Option - http://bit.ly/d6sT3c
At the derm today... | Facebook
facebook.com — “Rheumatoid Arthritis Warrior wrote: At the derm today for a biopsy of... Join Facebook to connect with Rheumatoid Arthritis Warrior and others you may know.” View full resource at facebook.com
Most Recently Shared on April 28, 2011 at 2:17 am By:
At the derm today for a biopsy of possible vasculitis: PA #1 interviews me on my health/RA then tells me to... http://fb.me/UpbyrbyO
FDA allows use of Genentech's Rituxan for 2 orphan diseases - Related Stories - AHIP Solutions SmartBrief
smartbrief.com — “The FDA authorized Genentech to promote blockbuster drug Rituxan as a treatment for Wegener's granulomatosis and microscopic polyangiitis, which are rare vasculitis-causing disorders. Rituxan is already used in patients with non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthri--” View full resource at smartbrief.com
Most Recently Shared on April 20, 2011 at 3:33 pm By:
Clara Song Pediatrician, Physician, and Doctor
FDA allows use of Genentech's Rituxan for 2 orphan diseases http://sbne.ws/r/7iOF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
science news
-
Dr Steven Siwek
The Pain Center of Arizona is led by Mayo Clinic trained pain physician, Steven M. Siwek, MD. who was named a Top Doctor by Phoenix Magazine in 2009.
-
OrganizedWisdom RA
Organizing rheumatoid arthritis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
